X
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
https://pharmaphorum.com/news/lillys-taltz-scrapes-win-against-humira-in-psoriatic-arthritis/
psoriatic arthritis
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Swiss pharma hopes to bounce back from Q1 sales disappointment
Novartis tests Cosentyx against Humira and biosimilars
Trials will cover psoriatic arthritis and ankylosing spondylitis
Pfizer’s Xeljanz approved in psoriatic arthritis
Xeljanz is first JAK inhibitor approved in psoriatic arthritis
Celgene’s Otezla on course to become blockbuster
Psoriasis drug surges in Q2.